Gurukul Ayurvedpharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.80 M
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 49.73%
- Profit Growth 49.44%
- Ebitda -121.05%
- Net Worth -4.06%
- Total Assets -9.08%
About Gurukul Ayurvedpharmacy
Gurukul Ayurvedpharmacy Private Limited (GAPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 October 2014 and has a history of Ten years and three months. Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.80 M, as per Ministry of Corporate Affairs (MCA) records.
Shalini Parashar and Seema Pandey serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999UR2014PTC001296
-
Company No.
001296
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Oct 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Gurukul Ayurvedpharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Parashar
|
Director | 05-Jan-2015 | Current |
|
Seema Pandey
|
Additional Director | 31-Aug-2017 | Current |
Financial Performance of Gurukul Ayurvedpharmacy.
Gurukul Ayurvedpharmacy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.73% increase. The company also saw a substantial improvement in profitability, with a 49.44% increase in profit. The company's net worth dipped by a decrease of 4.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gurukul Ayurvedpharmacy?
In 2023, Gurukul Ayurvedpharmacy had a public holding of 99.49%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Clove Aroma & Herbals Private LimitedShalini Parashar is a mutual person
-
Flying Star India Retails Private Limited
Shalini Parashar is a mutual person
-
Rsil Holdings Private Limited
Seema Pandey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gurukul Ayurvedpharmacy?
Unlock and access historical data on people associated with Gurukul Ayurvedpharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gurukul Ayurvedpharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gurukul Ayurvedpharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
